Literature DB >> 3972002

Observations on the metabolic effects of partial jejunoileal bypass in streptozotocin-treated rats.

E Morsiani, M C Carpanelli.   

Abstract

A 50% small bowel bypass was performed in diabetic rats (streptozotocin-treated) and in normal rats. Normal rats and diabetic rats were used as controls. Values of fasting blood glucose and oral glucose tolerance test showed a normalization and the disappearance of glycosuria, polyuria, polydipsia and hyperphagia in diabetic rats after surgery. Mean loss of weight 3 months after surgery was 9.1% in normal bypassed rats and 60.5% in the diabetic controls. After an initial postoperative weight loss of 33.4%, the diabetic bypassed rats gained subsequently their previous weight plus an increase of 7.2%. Improvement in carbohydrate metabolism appears to be independent of loss of weight and decrease in food intake in lean diabetic rats. Amelioration of diabetes after jejunoileal bypass is the result of several metabolic consequences, particularly the malabsorption of carbohydrates, fats and amino acids.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3972002     DOI: 10.1159/000128443

Source DB:  PubMed          Journal:  Eur Surg Res        ISSN: 0014-312X            Impact factor:   1.745


  3 in total

1.  Side-to-side jejunoileal anastomosis plus proximal loop ligation: a novel intestinal bypass model for diabetic rats.

Authors:  Jinyuan Duan; Lianwen Yuan; Jianping Zhou
Journal:  Obes Surg       Date:  2014-01       Impact factor: 4.129

2.  Ileal interposition improves glucose tolerance in low dose streptozotocin-treated diabetic and euglycemic rats.

Authors:  April D Strader; Trine Ryberg Clausen; Sean Z Goodin; Donna Wendt
Journal:  Obes Surg       Date:  2008-11-07       Impact factor: 4.129

3.  Duodenal-Jejunal bypass improves glucose homeostasis in association with decreased proinflammatory response and activation of JNK in the liver and adipose tissue in a T2DM rat model.

Authors:  Chunxiao Hu; Qingbo Su; Feng Li; Guangyong Zhang; Dong Sun; Haifeng Han; Shaozhuang Liu; Sanyuan Hu
Journal:  Obes Surg       Date:  2014-09       Impact factor: 4.129

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.